Annual report pursuant to Section 13 and 15(d)

Financial Instruments - Additional Information (Details)

v3.22.4
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 08, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Marketable equity securities $ 18,529    
Gross unrealized loss 1,476    
Investments in privately held entities $ 11,800 $ 5,000  
Company X | Contingent Consideration - Company X      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration (Note 3)     $ 3,000